TuHURA Biosciences Inc. (HURA) Company Profile & Statistics

TuHURA Biosciences Inc.
HURA
(Nasdaq - US)
Open
5.32
-0.21 (-3.80%)
in:usd•As of: Oct 22, 2024 12:38 UTC -4
Open
5.00
High
5.40
Low
4.77

About TuHURA Biosciences Inc.

CEO

Robert E. Hoffman

Headquarters

9920 pacific heights blvd, suite 150

san diego, ca 92121, united states

Auditor

Marcum llp

Employees

Share Holders

442

Website

www.kintara.com

Industry

biotechnology

Sector

health technology

Company Overview

Kintara Therapeutics Inc. is a biopharmaceutical company. It is focused on the development of new solid tumor cancer therapies. The company's program includes VAL-083 for GBM and REM-001 for cutaneous metastatic breast cancer, which are in clinical stage. Kintara Therapeutics Inc. is based in San Diego, California.

TuHURA Biosciences Inc. Statistics

Valuation Measures

Market Capitalization ²	8.46M
Enterprise Value	3.55M
Enterprise Value/EBITDA (ttm)	-0.42
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	674.16%
Return on Assets (ttm)	-199.86%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-8.40M
Net Income Avi to Common (ttm)	-8.50M
Diluted EPS (ttm)	-142.31

Share Statistics

Beta (5Y Monthly)	0.82
52-Week Change	-92.81%
S&P500 52-Week Change	38.56%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	55.66M
Dividend Yield	0.00%
Float ⁴	1.59M
% Held by Insiders	0.20%
% Held by Institutions	0.62%

Balance Sheet

Total Cash (mrq)	4.91M
Total Cash Per Share (mrq)	0.09
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	2.45%
Quick Ratio (mrq)	2.45%
Book Value Per Share (mrq)	0.07

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.27
Free Cash Flow (ytd)	-7.20M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

TuHURA Biosciences Inc.

Trade With A Regulated Broker